IM Cannabis Corp.

CNSX:IMCC Stock Report

Market Cap: CA$11.1m

IM Cannabis Management

Management criteria checks 2/4

IM Cannabis' CEO is Oren Shuster, appointed in Oct 2019, has a tenure of 5.08 years. total yearly compensation is CA$808.07K, comprised of 58.9% salary and 41.1% bonuses, including company stock and options. directly owns 20.73% of the company’s shares, worth CA$2.31M. The average tenure of the management team and the board of directors is 3.2 years and 2.2 years respectively.

Key information

Oren Shuster

Chief executive officer

CA$808.1k

Total compensation

CEO salary percentage58.9%
CEO tenure5.1yrs
CEO ownership20.7%
Management average tenure3.2yrs
Board average tenure2.2yrs

Recent management updates

Recent updates

Slammed 28% IM Cannabis Corp. (CSE:IMCC) Screens Well Here But There Might Be A Catch

Sep 13
Slammed 28% IM Cannabis Corp. (CSE:IMCC) Screens Well Here But There Might Be A Catch

A Piece Of The Puzzle Missing From IM Cannabis Corp.'s (CSE:IMCC) Share Price

Jul 30
A Piece Of The Puzzle Missing From IM Cannabis Corp.'s (CSE:IMCC) Share Price

Potential Upside For IM Cannabis Corp. (CSE:IMCC) Not Without Risk

Jul 19
Potential Upside For IM Cannabis Corp. (CSE:IMCC) Not Without Risk

Health Check: How Prudently Does IM Cannabis (CSE:IMCC) Use Debt?

Dec 24
Health Check: How Prudently Does IM Cannabis (CSE:IMCC) Use Debt?

Don't Ignore The Fact That This Insider Just Sold Some Shares In IM Cannabis Corp. (CSE:IMCC)

Feb 05
Don't Ignore The Fact That This Insider Just Sold Some Shares In IM Cannabis Corp. (CSE:IMCC)

What Percentage Of IM Cannabis Corp. (CSE:IMCC) Shares Do Insiders Own?

Jan 08
What Percentage Of IM Cannabis Corp. (CSE:IMCC) Shares Do Insiders Own?

CEO Compensation Analysis

How has Oren Shuster's remuneration changed compared to IM Cannabis's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

-CA$13m

Jun 30 2024n/an/a

-CA$14m

Mar 31 2024n/an/a

-CA$15m

Dec 31 2023CA$808kCA$476k

-CA$9m

Sep 30 2023n/an/a

-CA$15m

Jun 30 2023n/an/a

-CA$17m

Mar 31 2023n/an/a

-CA$17m

Dec 31 2022CA$2mCA$506k

-CA$23m

Sep 30 2022n/an/a

-CA$22m

Jun 30 2022n/an/a

-CA$16m

Mar 31 2022n/an/a

-CA$10m

Dec 31 2021CA$2mCA$516k

CA$91k

Sep 30 2021n/an/a

-CA$10m

Jun 30 2021n/an/a

-CA$12m

Mar 31 2021n/an/a

-CA$24m

Dec 31 2020CA$742kCA$424k

-CA$29m

Sep 30 2020n/an/a

-CA$7m

Jun 30 2020n/an/a

-CA$10m

Mar 31 2020n/an/a

-CA$982k

Dec 31 2019CA$2mCA$357k

-CA$7m

Compensation vs Market: Oren's total compensation ($USD577.98K) is above average for companies of similar size in the Canadian market ($USD169.37K).

Compensation vs Earnings: Oren's compensation has been consistent with company performance over the past year.

CEO

Oren Shuster

5.1yrs

Tenure

CA$808,068

Compensation

Mr. Oren Shuster serves as the Co-owner of IMC Ltd. Mr. Shuster serves as Chief Executive Officer and Director of IM Cannabis Corp. since October 11, 2019. Mr. Shuster is a leading figure in the medical ca...

Leadership Team

NamePositionTenureCompensationOwnership
Oren Shuster
CEO & Director5.1yrsCA$808.07k20.73%
CA$ 2.3m
Uri Birenberg
Chief Financial Officer1.1yrsCA$325.72kno data
Richard Balla
Chief Executive Officer of Adjupharm4.8yrsCA$293.97k0.029%
CA$ 3.3k
Anna Taranko
Director Investor & Public Relationsno datano datano data
Michal Nissimov
General Counsel1.6yrsno datano data

3.2yrs

Average Tenure

Experienced Management: IMCC's management team is considered experienced (3.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Oren Shuster
CEO & Director5.1yrsCA$808.07k20.73%
CA$ 2.3m
Shmulik Arbel
Directorless than a yearno data1.84%
CA$ 205.2k
Mordechai Marcus
Independent Director2.2yrsCA$96.66kno data
Brian Schinderle
Independent Director3.8yrsCA$135.32kno data
Einat Zakariya
Independent Director2.2yrsCA$93.16k2.06%
CA$ 228.9k

2.2yrs

Average Tenure

Experienced Board: IMCC's board of directors are not considered experienced ( 2.2 years average tenure), which suggests a new board.